# Fabric.AI, Inc.: financial statements, quarterly

FABC · Nasdaq · CIK 1086745 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fabc.md) · [Financials](/companies/fabc/financials.md) · [Filings](/companies/fabc/filings.md) · [Insiders](/companies/fabc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fabc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001493152-24-045893.md) | [0.2 d](/filings/0001641172-25-001705.md) | [0.1](/filings/0001641172-25-010337.md) | [0.0 d](/filings/0001641172-25-023974.md) | [0.0](/filings/0001493152-25-023588.md) | [0.0 d](/filings/0001493152-26-013650.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [0.2](/filings/0001493152-24-045893.md) | [4.4 d](/filings/0001641172-25-001705.md) | [1.2](/filings/0001641172-25-010337.md) | [1.1](/filings/0001641172-25-023974.md) | [0.3](/filings/0001493152-25-023588.md) | [4.1 d](/filings/0001493152-26-013650.md) | not reported | [0.2](/filings/0001493152-26-038445.md) | [0.7](/filings/0001493152-25-023588.md) | [0.0 d](/filings/0001493152-26-013650.md) | not reported | not reported |
| Gross profit | $m | [(0.1)](/filings/0001493152-24-045893.md) | [(4.2) d](/filings/0001641172-25-001705.md) | [(1.1)](/filings/0001641172-25-010337.md) | [(1.1)](/filings/0001641172-25-023974.md) | [(0.3)](/filings/0001493152-25-023588.md) | [(4.1) d](/filings/0001493152-26-013650.md) | not reported | [(0.2)](/filings/0001493152-26-038445.md) | [(0.7)](/filings/0001493152-25-023588.md) | [0.0 d](/filings/0001493152-26-013650.md) | not reported | not reported |
| Research and development | $m | [1.3](/filings/0001493152-24-045893.md) | [1.5 d](/filings/0001641172-25-001705.md) | [0.8](/filings/0001641172-25-010337.md) | [0.6](/filings/0001641172-25-023974.md) | [0.0](/filings/0001493152-25-023588.md) | [0.1 d](/filings/0001493152-26-013650.md) | [0.3](/filings/0001493152-26-023860.md) | [0.3](/filings/0001493152-26-038445.md) | [0.3](/filings/0001493152-25-023588.md) | [0.4 d](/filings/0001493152-26-013650.md) | [0.1](/filings/0001493152-26-023860.md) | [0.7](/filings/0001493152-26-038445.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(6.2)](/filings/0001493152-24-045893.md) | [(9.9) d](/filings/0001641172-25-001705.md) | [(5.2)](/filings/0001641172-25-010337.md) | [(4.0)](/filings/0001641172-25-023974.md) | [(1.9)](/filings/0001493152-25-023588.md) | [(8.3) d](/filings/0001493152-26-013650.md) | [(2.0)](/filings/0001493152-26-023860.md) | [(1.8)](/filings/0001493152-26-038445.md) | [(3.5)](/filings/0001493152-25-023588.md) | [(3.2) d](/filings/0001493152-26-013650.md) | [(1.7)](/filings/0001493152-26-023860.md) | [(3.3)](/filings/0001493152-26-038445.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(12.6)](/filings/0001493152-24-045893.md) | [(10.1) d](/filings/0001641172-25-001705.md) | [(3.6)](/filings/0001493152-25-023588.md) | [6.9](/filings/0001493152-25-023588.md) | [0.6](/filings/0001493152-25-023588.md) | [(5.6) d](/filings/0001493152-26-013650.md) | [0.8](/filings/0001493152-26-038445.md) | [(14.1)](/filings/0001493152-26-038445.md) | [(2.8)](/filings/0001493152-25-023588.md) | [(5.0) d](/filings/0001493152-26-013650.md) | [(2.4)](/filings/0001493152-26-038445.md) | [(12.5)](/filings/0001493152-26-038445.md) |
| Diluted EPS | $ per share | [(2.99)](/filings/0001493152-24-045893.md) | not reported | [(1.46)](/filings/0001641172-25-010337.md) | [2.17](/filings/0001641172-25-023974.md) | [(3.96)](/filings/0001493152-25-023588.md) | not reported | [(0.20)](/filings/0001493152-26-023860.md) | [(29.87)](/filings/0001493152-26-038445.md) | [(3.84)](/filings/0001493152-25-023588.md) | not reported | [(2.42)](/filings/0001493152-26-023860.md) | [(3.52)](/filings/0001493152-26-038445.md) |
| Basic EPS | $ per share | [(2.99)](/filings/0001493152-24-045893.md) | not reported | [(1.46)](/filings/0001641172-25-010337.md) | [12.45](/filings/0001641172-25-023974.md) | [(3.96)](/filings/0001493152-25-023588.md) | not reported | [(0.20)](/filings/0001493152-26-023860.md) | [(29.87)](/filings/0001493152-26-038445.md) | [(3.84)](/filings/0001493152-25-023588.md) | not reported | [(2.42)](/filings/0001493152-26-023860.md) | [(3.52)](/filings/0001493152-26-038445.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-04-27) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [33.4](/filings/0001641172-25-001705.md) | [5.5](/filings/0001641172-25-010337.md) | [14.1](/filings/0001641172-25-023974.md) | [2.7](/filings/0001493152-25-023588.md) | [16.0](/filings/0001493152-26-013650.md) | [12.8](/filings/0001493152-26-023860.md) | [5.1](/filings/0001493152-26-038445.md) | [7.3](/filings/0001493152-25-023588.md) | [5.0](/filings/0001493152-26-038445.md) | [3.3](/filings/0001493152-26-023860.md) | [7.5](/filings/0001493152-26-038445.md) | [3.6](/filings/0001493152-26-038445.md) |
| Current assets | $m | [49.0](/filings/0001641172-25-001705.md) | [44.3](/filings/0001493152-24-019973.md) | [42.0](/filings/0001493152-24-032672.md) | [33.4](/filings/0001493152-24-045893.md) | [21.3](/filings/0001493152-26-013650.md) | [15.7](/filings/0001641172-25-010337.md) | [8.8](/filings/0001641172-25-023974.md) | [13.8](/filings/0001493152-25-023588.md) | [9.2](/filings/0001493152-26-038445.md) | [8.0](/filings/0001493152-26-023860.md) | not reported | [32.4](/filings/0001493152-26-038445.md) |
| Total assets | $m | [52.9](/filings/0001641172-25-001705.md) | [47.9](/filings/0001493152-24-019973.md) | [45.0](/filings/0001493152-24-032672.md) | [35.9](/filings/0001493152-24-045893.md) | [21.7](/filings/0001493152-26-013650.md) | [16.2](/filings/0001641172-25-010337.md) | [9.2](/filings/0001641172-25-023974.md) | [15.7](/filings/0001493152-25-023588.md) | [11.4](/filings/0001493152-26-038445.md) | [9.5](/filings/0001493152-26-023860.md) | not reported | [49.7](/filings/0001493152-26-038445.md) |
| Current liabilities | $m | [4.3](/filings/0001641172-25-001705.md) | [4.0](/filings/0001493152-24-019973.md) | [6.5](/filings/0001493152-24-032672.md) | [5.1](/filings/0001493152-24-045893.md) | [4.2](/filings/0001493152-26-013650.md) | [7.1](/filings/0001641172-25-010337.md) | [7.6](/filings/0001641172-25-023974.md) | [1.9](/filings/0001493152-25-023588.md) | [1.6](/filings/0001493152-26-038445.md) | [1.6](/filings/0001493152-26-023860.md) | not reported | [1.7](/filings/0001493152-26-038445.md) |
| Total liabilities | $m | [27.5](/filings/0001641172-25-001705.md) | [26.1](/filings/0001493152-24-019973.md) | [18.0](/filings/0001493152-24-032672.md) | [14.0](/filings/0001493152-24-045893.md) | [9.5](/filings/0001493152-26-013650.md) | [9.8](/filings/0001641172-25-010337.md) | [22.3](/filings/0001641172-25-023974.md) | [2.0](/filings/0001493152-25-023588.md) | [1.7](/filings/0001493152-26-038445.md) | [1.6](/filings/0001493152-26-023860.md) | not reported | [21.4](/filings/0001493152-26-038445.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [14.1](/filings/0001493152-26-013650.md) | [7.0](/filings/0001493152-25-023588.md) | [12.8](/filings/0001493152-25-023588.md) | [11.5](/filings/0001493152-25-023588.md) | [4.7](/filings/0001493152-26-038445.md) | [3.0](/filings/0001493152-26-038445.md) | [(13.1)](/filings/0001493152-26-038445.md) | [8.3](/filings/0001493152-25-023588.md) | [3.7](/filings/0001493152-26-038445.md) | [1.2](/filings/0001493152-26-038445.md) | not reported | [11.2](/filings/0001493152-26-038445.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(6,409) d](/filings/0001493152-24-045893.md) | [(4,879) d](/filings/0001641172-25-001705.md) | [(4,682)](/filings/0001641172-25-010337.md) | [(2,152) d](/filings/0001641172-25-023974.md) | [(3,500) d](/filings/0001493152-25-023588.md) | [(2,981) d](/filings/0001493152-26-013650.md) | [(1,476)](/filings/0001493152-26-023860.md) | [(2,625) d](/filings/0001493152-26-038445.md) | [1,200](/filings/0001493152-25-023588.md) | [(1,650) d](/filings/0001493152-26-013650.md) | [(1,095)](/filings/0001493152-26-023860.md) | [(6,124) d](/filings/0001493152-26-038445.md) |
| Capital expenditure | $k | [805 d](/filings/0001493152-24-045893.md) | [66.8 d](/filings/0001641172-25-001705.md) | not reported | not reported | not reported | [36.5 d](/filings/0001493152-26-013650.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,637](/filings/0001493152-23-042134.md) | [4,665](/filings/0001493152-24-019973.md) | [4,685](/filings/0001493152-24-032672.md) | [4,744](/filings/0001493152-24-045893.md) | [4,929](/filings/0001641172-25-010337.md) | [1,040](/filings/0001641172-25-023974.md) | [429](/filings/0001493152-25-023588.md) | [8,541](/filings/0001493152-26-023860.md) | [555](/filings/0001493152-26-038445.md) | [946](/filings/0001493152-25-023588.md) | [1,456](/filings/0001493152-26-023860.md) | [4,140](/filings/0001493152-26-038445.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,003,613 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038445.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.